Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Novo Nordisk Pharma Operations A/S

Closing information (x1000 EUR)

Closing information 2021/12 2020/12 2019/12
Turnover 13,263 Less Arrow 10,646 More Arrow 10,849
Earnings before taxes 591 Less Arrow 502 More Arrow 518
Total assets 9,529 Less Arrow 7,350 More Arrow 7,486
Current assets 8,047 Less Arrow 6,523 Less Arrow 5,922
Current liabilities 5,714 Less Arrow 4,947 More Arrow 5,120
Equity capital 2,762 Less Arrow 2,337 Less Arrow 1,924
- share capital 67 Equal arrow 67 Equal arrow 67
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2021/12 2020/12 2019/12
Solvency 29.0% More Arrow 31.8% Less Arrow 25.7%
Turnover per employee
Profit as a percentage of turnover 4.5% More Arrow 4.7% More Arrow 4.8%
Return on assets (ROA)
Current ratio 140.8% Less Arrow 131.9% Less Arrow 115.7%
Return on equity (ROE) 21.4% More Arrow 21.5% More Arrow 26.9%
Change turnover 2,613 Less Arrow -248 More Arrow 2,635
Change turnover % 25% Less Arrow -2% More Arrow 32%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2021/12 2020/12 2019/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.